Chemotherapy for ovarian cancer - a consensus statement on standard practice

被引：54

作者：

Adams, M

Calvert, AH

Carmichael, J

Clark, PI

Coleman, RE

Earl, HM

Gallagher, CJ

Ganesan, TS

Gore, ME

Graham, JD

Harper, PG

Jayson, GC

Kaye, SB

Ledermann, JA

Osborne, RJ

Perren, TJ

Poole, CJ

Radford, JA

Rustin, GJS

Slevin, ML

Smyth, JF

Thomas, H

Wilkinson, PM

机构：

[1] Velindre Hosp, Cardiff, S Glam, Wales

[2] Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England

[3] City Hosp Nottingham, Nottingham, England

[4] Clatterbridge Ctr Oncol, Wirral, Merseyside, England

[5] Weston Pk Hosp, Sheffield, S Yorkshire, England

[6] Addenbrookes Hosp, Cambridge, England

[7] St Bartholomews Hosp, London, England

[8] John Radcliffe Hosp, Oxford OX3 9DU, England

[9] Royal Marsden Hosp, London SW3 6JJ, England

[10] Univ Edinburgh, Western Gen Hosp, Edinburgh, Midlothian, Scotland

[11] Guys Hosp, London SE1 9RT, England

[12] Christie Hosp, Manchester, Lancs, England

[13] Western Infirm & Associated Hosp, Beatson Oncol Ctr, Glasgow G11 6NT, Lanark, Scotland

[14] UCL Hosp, London WC1E 6AU, England

[15] Poole Gen Hosp, Dorset, England

[16] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England

[17] Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England

[18] Mt Vernon Hosp, Northwood, Middx, England

[19] Bristol Royal Infirm & Gen Hosp, Bristol, Avon, England

[20] Hammersmith Hosp, London, England

来源：

BRITISH JOURNAL OF CANCER | 1998年 / 78卷 / 11期

关键词：

D O I：

10.1038/bjc.1998.699

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1404 / 1406

页数：3

共 22 条

[1] ALLEN DG, 1993, ANN ONCOL, V4, P83
[2] ARAVANTINOS G, 1994, ANN ONCOL S8, V5, P102
[3] ATHANASSIOU A, 1994, P AN M AM SOC CLIN, V13, P870
[4] RESPONSE OF PATIENTS IN PHASE-II STUDIES OF CHEMOTHERAPY IN OVARIAN-CANCER - IMPLICATIONS FOR PATIENT TREATMENT AND THE DESIGN OF PHASE-II TRIALS
BLACKLEDGE, G
LAWTON, F
REDMAN, C
KELLY, K
[J]. BRITISH JOURNAL OF CANCER, 1989, 59 (04) : 650 - 653
[5] DUBOIS A, 1998, P AN M AM SOC CLIN, V17, pA1395
[6] EUROPEAN-CANADIAN RANDOMIZED TRIAL OF PACLITAXEL IN RELAPSED OVARIAN-CANCER - HIGH-DOSE VERSUS LOW-DOSE AND LONG VERSUS SHORT INFUSION
EISENHAUER, EA
HUININK, WWT
SWENERTON, KD
GIANNI, L
MYLES, J
VANDERBURG, MEL
KERR, I
VERMORKEN, JB
BUSER, K
COLOMBO, N
BACON, M
SANTABARBARA, P
ONETTO, N
WINOGRAD, B
CANETTA, R
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (12) : 2654 - 2666
[7] TREATMENT OF RELAPSED CARCINOMA OF THE OVARY WITH CISPLATIN OR CARBOPLATIN FOLLOWING INITIAL TREATMENT WITH THESE COMPOUNDS
GORE, ME
FRYATT, I
WILTSHAW, E
DAWSON, T
[J]. GYNECOLOGIC ONCOLOGY, 1990, 36 (02) : 207 - 211
[8] PACLITAXEL (TAXOL) IN RELAPSED AND REFRACTORY OVARIAN-CANCER - THE UK AND EIRE EXPERIENCE
GORE, ME
LEVY, V
RUSTIN, G
PERREN, T
CALVERT, AH
EARL, H
THOMPSON, JM
[J]. BRITISH JOURNAL OF CANCER, 1995, 72 (04) : 1016 - 1019
[9] MANAGEMENT OF OVARIAN-CANCER - REFERRAL TO A MULTIDISCIPLINARY TEAM MATTERS
JUNOR, EJ
HOLE, DJ
GILLIS, CR
[J]. BRITISH JOURNAL OF CANCER, 1994, 70 (02) : 363 - 370
[10] 2ND-LINE PLATINUM THERAPY IN PATIENTS WITH OVARIAN-CANCER PREVIOUSLY TREATED WITH CISPLATIN
MARKMAN, M
ROTHMAN, R
HAKES, T
REICHMAN, B
HOSKINS, W
RUBIN, S
JONES, W
ALMADRONES, L
LEWIS, JL
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (03) : 389 - 393

← 1 2 3 →